255 related articles for article (PubMed ID: 23623385)
1. Comparative in vitro activity of ceftaroline, ceftaroline-avibactam, and other antimicrobial agents against aerobic and anaerobic bacteria cultured from infected diabetic foot wounds.
Goldstein EJ; Citron DM; Merriam CV; Tyrrell KL
Diagn Microbiol Infect Dis; 2013 Jul; 76(3):347-51. PubMed ID: 23623385
[TBL] [Abstract][Full Text] [Related]
2. Ceftaroline plus avibactam demonstrates bactericidal activity against pathogenic anaerobic bacteria in a one-compartment in vitro pharmacokinetic/pharmacodynamic model.
Werth BJ; Rybak MJ
Antimicrob Agents Chemother; 2014; 58(1):559-62. PubMed ID: 24217692
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance study.
Karlowsky JA; Adam HJ; Baxter MR; Lagacé-Wiens PR; Walkty AJ; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 2013 Nov; 57(11):5600-11. PubMed ID: 23979759
[TBL] [Abstract][Full Text] [Related]
4. Activity of ceftaroline-avibactam tested against Gram-negative organism populations, including strains expressing one or more β-lactamases and methicillin-resistant Staphylococcus aureus carrying various staphylococcal cassette chromosome mec types.
Castanheira M; Sader HS; Farrell DJ; Mendes RE; Jones RN
Antimicrob Agents Chemother; 2012 Sep; 56(9):4779-85. PubMed ID: 22733066
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of ceftaroline combined with avibactam tested against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2010-2012).
Flamm RK; Farrell DJ; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2014 Apr; 78(4):449-56. PubMed ID: 24529941
[TBL] [Abstract][Full Text] [Related]
6. In vivo efficacy of humanized ceftaroline fosamil-avibactam exposures in a polymicrobial infection model.
Bhalodi AA; Crandon JL; Williams G; Nicolau DP
Antimicrob Agents Chemother; 2013 Nov; 57(11):5674-8. PubMed ID: 24041891
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).
Sader HS; Flamm RK; Jones RN
Diagn Microbiol Infect Dis; 2013 May; 76(1):61-8. PubMed ID: 23535208
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of ceftazidime, ceftaroline and aztreonam alone and in combination with avibactam against European Gram-negative and Gram-positive clinical isolates.
Testa R; Cantón R; Giani T; Morosini MI; Nichols WW; Seifert H; Stefanik D; Rossolini GM; Nordmann P
Int J Antimicrob Agents; 2015 Jun; 45(6):641-6. PubMed ID: 25748553
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations.
Yoshizumi A; Ishii Y; Aoki K; Testa R; Nichols WW; Tateda K
J Infect Chemother; 2015 Feb; 21(2):148-51. PubMed ID: 25444674
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity of ceftaroline-avibactam tested against clinical isolates collected from U.S. Medical Centers in 2010-2011.
Sader HS; Flamm RK; Jones RN
Antimicrob Agents Chemother; 2013 Apr; 57(4):1982-8. PubMed ID: 23380730
[TBL] [Abstract][Full Text] [Related]
12. Spectrum and potency of ceftaroline tested against leading pathogens causing community-acquired respiratory tract infections in Europe (2010).
Farrell DJ; Flamm RK; Jones RN; Sader HS
Diagn Microbiol Infect Dis; 2013 Jan; 75(1):86-8. PubMed ID: 23146404
[TBL] [Abstract][Full Text] [Related]
13.
Stone GG; Newell P; Bradford PA
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686147
[TBL] [Abstract][Full Text] [Related]
14. Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance Program.
Sader HS; Flamm RK; Farrell DJ; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S181-6. PubMed ID: 22903950
[TBL] [Abstract][Full Text] [Related]
15. Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents.
Citron DM; Goldstein EJ; Merriam CV; Lipsky BA; Abramson MA
J Clin Microbiol; 2007 Sep; 45(9):2819-28. PubMed ID: 17609322
[TBL] [Abstract][Full Text] [Related]
16. Ceftaroline activity against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2009-2011).
Pfaller MA; Flamm RK; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2014 Apr; 78(4):422-8. PubMed ID: 24445158
[TBL] [Abstract][Full Text] [Related]
17. Ceftaroline fosamil: a cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
Poon H; Chang MH; Fung HB
Clin Ther; 2012 Apr; 34(4):743-65. PubMed ID: 22444785
[TBL] [Abstract][Full Text] [Related]
18. Global trends of antimicrobial susceptibility to ceftaroline and ceftazidime-avibactam: a surveillance study from the ATLAS program (2012-2016).
Zhang H; Xu Y; Jia P; Zhu Y; Zhang G; Zhang J; Duan S; Kang W; Wang T; Jing R; Cheng J; Liu Y; Yang Q
Antimicrob Resist Infect Control; 2020 Oct; 9(1):166. PubMed ID: 33109242
[TBL] [Abstract][Full Text] [Related]
19. Characterizing the role of porin mutations in susceptibility of beta lactamase producing Klebsiella pneumoniae isolates to ceftaroline and ceftaroline-avibactam.
Khalid A; Lubián AF; Ma L; Lin RCY; Iredell JR
Int J Infect Dis; 2020 Apr; 93():252-257. PubMed ID: 32061861
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections.
Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
Antimicrob Agents Chemother; 2006 Nov; 50(11):3959-62. PubMed ID: 16982780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
